Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. (2021)

First Author: Conde J
Attributed to:  ZMYND8-regulation of MITF as potential therapeutic target in melanoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.68480

Publication URI: https://www.repository.cam.ac.uk/handle/1810/321359

Type: Journal Article/Review